No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
CRL250117C200000
- 0.57
- -1.64-74.21%
15min DelayClose Jan 10 16:00 ET
0.57High0.57Low
0.57Open2.21Pre Close3 Volume108 Open Interest200.00Strike Price171.00Turnover65.88%IV7.76%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.57Extrinsic Value100Contract SizeAmericanOptions Type0.1859Delta0.0188Gamma132.94Leverage Ratio-0.3913Theta0.0045Rho24.71Eff Leverage0.0579Vega
Intraday
- 5D
- Daily
News
Charles River Stock Rises 81% in a Year: Here's What to Know
Deciphex Secures $32.3M Series C to Address Global Pathology Shortage
Michael Scholle Appointed CEO of Tango Biosciences
Citi Says Avoid These Stocks in '25; SA Quant Ratings Says Not so Fast
Clinical Trials Outsourcing Market Focused Insights 2024-2029 With Charles River, IQVIA, ICON, Laboratory Corp of America, Syneos Health, Thermo Fischer Scientific, WuXi AppTec, and Paraxel Dominating - ResearchAndMarkets.com
Preclinical Medical Device Testing Services Market Outlook, 2025-2035 - Dominated by Charles River Laboratories Int'l, Eurofins Scientific, SGS, WuXi AppTec, and Pace Analytical Services